Addiction: A Family Affair
Addiction: A Family Affair | Scott Teitelbaum


Scott Teitelbaum, MDOriginally from Staten Island, New York, Dr. Scott Teitelbaum received his undergraduate degree in Psychology at Lehigh University, attended medical school at Rochester University, and completed his residency in Pediatrics at the University of Connecticut.  He served in pediatric private practice for ten years before completing a Postdoctoral Fellowship in Addiction Medicine and another in Child Psychiatry at the University of Florida.
He joined the UF Department of Psychiatry faculty in 2002 and now serves as the Department Vice Chair and Clinical Chief of the Addiction Medicine Division.  His expertise includes chemical dependence and compulsive gambling.

Board certified as a Pediatrician, certified by the American Society of Addiction Medicine, and a certified medical review officer, Dr. Teitelbaumserves as Medical Director for the Florida Recovery Center (FRC) and as Director of Adolescent Recovery Services.  He is a Clinical Associate Professor in two departments:  Psychiatry and Pediatrics.

In 2010, Dr. Teitelbaum was inducted into the Conway Hunter Society, which is dedicated to excellence in addiction treatment programs, fighting the stigma associated with the disease of alcoholism and addiction to other drugs.

Dr. Teitelbaum teaches ABAM/ASAM Fellows and medical students through Florida Recovery Center  Partical Hospitalization Program rounds, clinical teaching, and fundamental education on Addition Medicine, as well as through lectures on general addiction principles and the treatment of impaired professionals.

He has been invited to speak around the country, including as Key Note Speaker, and has presented Ground Rounds at numerous hospitals.  Dr. Teitelbaum has been consulted by the White House Executive Office of the President to help with the media campaign on the use of marijuana by children and adolescents and also serves as an Expert Panelist and Speaker for The National Youth Anti-Drug Media Campaign, sponsored by The White House, Office of National Drug Control Policy.